AVNS
Avanos Medical Inc
NYSE: AVNS · HEALTHCARE · MEDICAL DEVICES
$24.64
-0.06% today
Updated 2026-04-30
Market cap
$1.15B
P/E ratio
—
P/S ratio
1.64x
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$9 – $25
Volume
1.4M
Avanos Medical Inc (AVNS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.66B | $1.68B | $1.68B | $1.67B | $1.57B | $566.20M | $611.60M | $652.30M | $697.60M | $714.80M | $744.60M | $684.10M | $673.30M | $687.80M | $701.20M |
| Revenue growth (YoY) | — | +1.5% | -0.4% | -0.3% | -5.8% | -64.0% | +8.0% | +6.7% | +6.9% | +2.5% | +4.2% | -8.1% | -1.6% | +2.2% | +1.9% |
| Cost of revenue | $1.07B | $1.08B | $1.07B | $1.06B | $1.04B | $269.00M | $274.70M | $261.40M | $295.40M | $324.20M | $364.70M | $289.90M | $293.60M | $306.50M | $352.20M |
| Gross profit | $590.80M | $602.50M | $612.20M | $608.60M | $531.60M | $297.20M | $336.90M | $390.90M | $402.20M | $390.60M | $379.90M | $394.20M | $379.70M | $381.30M | $349.00M |
| Gross margin | 35.6% | 35.8% | 36.5% | 36.4% | 33.8% | 52.5% | 55.1% | 59.9% | 57.7% | 54.6% | 51.0% | 57.6% | 56.4% | 55.4% | 49.8% |
| R&D | $31.20M | $33.00M | $37.90M | $33.60M | $32.30M | $38.40M | $38.20M | $41.80M | $37.70M | $34.90M | $32.30M | $30.60M | $27.20M | $26.20M | $23.10M |
| SG&A | $351.70M | $343.00M | $351.40M | $424.50M | $398.50M | $411.10M | $321.70M | $340.40M | $399.10M | $332.60M | $300.30M | $341.90M | $335.00M | $318.50M | $315.60M |
| Operating income | $207.90M | $226.50M | $222.90M | $311.50M | $154.80M | $-69.40M | $-16.00M | $34.90M | $-5.40M | $70.90M | $86.80M | $41.90M | $65.00M | $40.00M | $-61.60M |
| Operating margin | 12.5% | 13.5% | 13.3% | 18.6% | 9.8% | -12.3% | -2.6% | 5.4% | -0.8% | 9.9% | 11.7% | 6.1% | 9.7% | 5.8% | -8.8% |
| EBITDA | $265.90M | $288.20M | $297.10M | $182.20M | $-311.40M | $-65.50M | $-600000.00 | $37.00M | $-12.10M | $-2.00M | $48.90M | $77.80M | $50.60M | $-345.60M | $-33.20M |
| EBITDA margin | 16.0% | 17.1% | 17.7% | 10.9% | -19.8% | -11.6% | -0.1% | 5.7% | -1.7% | -0.3% | 6.6% | 11.4% | 7.5% | -50.2% | -4.7% |
| EBIT | $214.80M | $230.60M | $227.90M | $97.20M | $-377.40M | $-106.50M | $-40.60M | $3.50M | $-49.00M | $-44.90M | $10.60M | $36.70M | $7.10M | $-391.10M | $-62.20M |
| Interest expense | $200000.00 | $800000.00 | $100000.00 | $6.00M | $33.10M | $32.70M | $31.60M | $26.40M | $15.00M | $15.60M | $3.30M | $10.00M | $15.00M | $12.20M | $4.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $142.40M | $152.60M | $154.60M | $27.10M | $-426.30M | $39.80M | $79.30M | $57.50M | $-45.90M | $-27.20M | $6.30M | $50.50M | $-61.80M | $-392.10M | $-67.90M |
| Net income growth (YoY) | — | +7.2% | +1.3% | -82.5% | -1673.1% | +109.3% | +99.2% | -27.5% | -179.8% | +40.7% | +123.2% | +701.6% | -222.4% | -534.5% | +82.7% |
| Profit margin | 8.6% | 9.1% | 9.2% | 1.6% | -27.1% | 7.0% | 13.0% | 8.8% | -6.6% | -3.8% | 0.8% | 7.4% | -9.2% | -57.0% | -9.7% |